FUJIFILM reshapes life sciences leadership to accelerate cell therapy and iPSC expansion
Tomoyuki Hasegawa has been appointed CEO of FUJIFILM Biotechnologies California
Tomoyuki Hasegawa has been appointed CEO of FUJIFILM Biotechnologies California
We are building the bridge between complex molecular data and everyday clinical decisions
The facility integrates advanced scientific infrastructure and specialised workflows to support complex drug delivery systems, sterile injectables, and differentiated dosage forms
A first-of-its-kind national platform honouring the people and institutions shaping the next chapter of life sciences in India
Adya Anubhuti launches ADHD Copilot, an AI-powered platform designed to reduce stress and mental overload
On a full-year basis, revenue from operations for FY26 grew 18.9 percent year-on-year to Rs 827.87 crore compared to Rs 696.48 crore in FY25
Company launches clinical study of AI-designed oral formulation following MHRA approval, marking a major milestone in AI-driven drug development.
Sarin will focus on advancing scalable AI-driven platforms and strengthening the company’s global data science capabilities across healthcare and enterprise technology domains
Our Global Capability Center (GCC) in Bengaluru drives our major software development initiatives. Complementing this, our Bengaluru facility manufactures antibodies for research and diagnostics. Through these integrated technology and biotech operations, we are proud to contribute to India’s growth story in the life sciences sector.
Subscribe To Our Newsletter & Stay Updated